MiRNA expression profile reveals a prognostic signature for esophageal squamous cell carcinoma

Cancer Letters

Volumn 350, Issue 1-2, 2014, Pages 34-42

  Chen, Zhaoli ^a   Li, Jiagen ^a   Tian, Liqing ^b   Zhou, Chengcheng ^a   Gao, Yibo ^a   Zhou, Fang ^a   Shi, Susheng ^a   Feng, Xiaoli ^a   Sun, Nan ^a   Yao, Ran ^a   Shao, Kang ^a   Li, Ning ^a   Qiu, Bin ^a   Tan, Fengwei ^a   He, Jie ^a  

^a CANCER HOSPITAL   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Biomarker; Esophageal squamous cell carcinoma; MicroRNA; Prognosis; Signature

Indexed keywords

MICRORNA;

ACCURACY; ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

BIOMARKER; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; MICRORNA; PROGNOSIS; SIGNATURE;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL; TUMOR MARKERS, BIOLOGICAL;

EID: 84901340289     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.04.013     Document Type: Article

References (37)

1. Yang L., Parkin D.M., Ferlay J., Li L., Chen Y. Estimates of cancer incidence in China for, and projections for 2005. Cancer Epidemiol Biomarkers Prevent 2000, 14(2005):243-250.
2. Su H., Hu N., Yang H.H., Wang C., Takikita M., Wang Q.H., Giffen C., Clifford R., Hewitt S.M., Shou J.Z., Goldstein A.M., Lee M.P., Taylor P.R. Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes. Clin. Cancer Res. 2011, 17:2955-2966.
3. Guo Y., Chen Z., Zhang L., Zhou F., Shi S., Feng X., Li B., Meng X., Ma X., Luo M., Shao K., Li N., Qiu B., Mitchelson K., Cheng J., He J. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res. 2008, 68:26-33.
4. Campbell P.J., Pleasance E.D., Stephens P.J., Dicks E., Rance R., Goodhead I., Follows G.A., Green A.R., Futreal P.A., Stratton M.R. Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc. Natl. Acad. Sci. USA 2008, 105:13081-13086.
5. Ji L., Cao X.F., Wang H.M., Li Y.S., Zhu B., Xiao J., Wang D. Expression level of beta-catenin is associated with prognosis of esophageal carcinoma. World J. Gastroenterol. 2007, 13:2622-2625.
6. Tong M., Chan K.W., Bao J.Y., Wong K.Y., Chen J.N., Kwan P.S., Tang K.H., Fu L., Qin Y.R., Lok S., Guan X.Y., Ma S. Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma. Cancer Res. 2012, 72:6024-6035.
7. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., Golub T.R. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
8. * promotes invasiveness of glioblastoma cells. J. Clin. Invest. 2012, 122:4059-4076.
9. Kong K.L., Kwong D.L., Chan T.H., Law S.Y., Chen L., Li Y., Qin Y.R., Guan X.Y. MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 2012, 61:33-42.
10. Chen Z.L., Zhao X.H., Wang J.W., Li B.Z., Wang Z., Sun J., Tan F.W., Ding D.P., Xu X.H., Zhou F., Tan X.G., Hang J., Shi S.S., Feng X.L., He J. MicroRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J. Biol. Chem. 2011, 286:10725-10734.
11. Zhu C.Q., Ding K., Strumpf D., Weir B.A., Meyerson M., Pennell N., Thomas R.K., Naoki K., Ladd-Acosta C., Liu N., Pintilie M., Der S., Seymour L., Jurisica I., Shepherd F.A., Tsao M.S. Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. J. Clin. Oncol. 2010, 28:4417-4424.
12. Yu S.L., Chen H.Y., Chang G.C., Chen C.Y., Chen H.W., Singh S., Cheng C.L., Yu C.J., Lee Y.C., Chen H.S., Su T.J., Chiang C.C., Li H.N., Hong Q.S., Su H.Y., Chen C.C., Chen W.J., Liu C.C., Chan W.K., Li K.C., Chen J.J., Yang P.C. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008, 13:48-57.
13. Liu N., Chen N.Y., Cui R.X., Li W.F., Li Y., Wei R.R., Zhang M.Y., Sun Y., Huang B.J., Chen M., He Q.M., Jiang N., Chen L., Cho W.C., Yun J.P., Zeng J., Liu L.Z., Li L., Guo Y., Wang H.Y., Ma J. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet. Oncol. 2012, 13:633-641.
14. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., Iorio M.V., Visone R., Sever N.I., Fabbri M., Iuliano R., Palumbo T., Pichiorri F., Roldo C., Garzon R., Sevignani C., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., Croce C.M. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. New. Engl. J. Med. 2005, 353:1793-1801.
15. Edge S.B., Compton C.C. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 2010, 17:1471-1474.
16. McShane L.M., Altman D.G., Sauerbrei W., Taube S.E., Gion M., Clark G.M. REporting recommendations for tumour MARKer prognostic studies (REMARK). Eur. J. Cancer 2005, 41:1690-1696.
17. Bolstad B.M., Irizarry R.A., Astrand M., Speed T.P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193.
18. Lacson R., Pitzer E., Kim J., Galante P., Hinske C., Ohno-Machado L. DSGeo: software tools for cross-platform analysis of gene expression data in GEO. J. Biomed. Inform. 2010, 43:709-715.
19. Schwarz D.F., Konig I.R., Ziegler A. On safari to Random Jungle: a fast implementation of Random Forests for high-dimensional data. Bioinformatics 2010, 26:1752-1758.
20. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
21. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., Rajewsky N. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
22. Wang X. MiRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 2008, 14:1012-1017.
23. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
24. Li J., Chen Z., Tian L., Zhou C., He M.Y., Gao Y., Wang S., Zhou F., Shi S., Feng X., Sun N., Liu Z., Skogerboe G., Dong J., Yao R., Zhao Y., Sun J., Zhang B., Yu Y., Shi X., Luo M., Shao K., Li N., Qiu B., Tan F., Chen R., He J. LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma. Gut 2014.
25. Chen H.Y., Yu S.L., Chen C.H., Chang G.C., Chen C.Y., Yuan A., Cheng C.L., Wang C.H., Terng H.J., Kao S.F., Chan W.K., Li H.N., Liu C.C., Singh S., Chen W.J., Chen J.J., Yang P.C. A five-gene signature and clinical outcome in non-small-cell lung cancer. New Engl. J. Med. 2007, 356:11-20.
26. Chen D.T., Hsu Y.L., Fulp W.J., Coppola D., Haura E.B., Yeatman T.J., Cress W.D. Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer. J. Natl. Cancer Inst. 2011, 103:1859-1870.
27. Uesugi A., Kozaki K., Tsuruta T., Furuta M., Morita K., Imoto I., Omura K., Inazawa J. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res. 2011, 71:5765-5778.
28. Liu Y., Yan W., Zhang W., Chen L., You G., Bao Z., Wang Y., Wang H., Kang C., Jiang T. MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1. Oncol. Rep. 2012, 28:1013-1021.
29. Tatarano S., Chiyomaru T., Kawakami K., Enokida H., Yoshino H., Hidaka H., Yamasaki T., Kawahara K., Nishiyama K., Seki N., Nakagawa M. MiR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer. Int. J. Oncol. 2011, 39:13-21.
30. Alajez N.M., Lenarduzzi M., Ito E., Hui A.B., Shi W., Bruce J., Yue S., Huang S.H., Xu W., Waldron J., O'Sullivan B., Liu F.F. MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res. 2011, 71:2381-2391.
31. Gao C., Zhang Z., Liu W., Xiao S., Gu W., Lu H. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer 2010, 116:41-49.
32. Lin R.J., Xiao D.W., Liao L.D., Chen T., Xie Z.F., Huang W.Z., Wang W.S., Jiang T.F., Wu B.L., Li E.M., Xu L.Y. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. J. Surg. Oncol. 2012, 105:175-182.
33. Zhang J., Luo N., Luo Y., Peng Z., Zhang T., Li S. MicroRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Int. J. Oncol. 2012, 40:747-756.
34. Srivastava S.K., Bhardwaj A., Singh S., Arora S., Wang B., Grizzle W.E., Singh A.P. MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Carcinogenesis 2011, 32:1832-1839.
35. Watanabe A., Tagawa H., Yamashita J., Teshima K., Nara M., Iwamoto K., Kume M., Kameoka Y., Takahashi N., Nakagawa T., Shimizu N., Sawada K. The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 2011, 25:1324-1334.
36. Schaefer A., Jung M., Mollenkopf H.J., Wagner I., Stephan C., Jentzmik F., Miller K., Lein M., Kristiansen G., Jung K. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int. J. Cancer 2010, 126:1166-1176.
37. Childs G., Fazzari M., Kung G., Kawachi N., Brandwein-Gensler M., McLemore M., Chen Q., Burk R.D., Smith R.V., Prystowsky M.B., Belbin T.J., Schlecht N.F. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am. J. Pathol. 2009, 174:736-745.